Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Friday, 3 March 2023, 09:18 HKT/SGT
Share:
H World Group sells its shares in Accor, both companies to continue partnership in developing their hotel operations in China

HONG KONG, Mar 3, 2023 - (ACN Newswire) - H World Group recently announced that it completed the disposal of its 3.7% stake in Accor. The proceeds of this transaction will be redeployed for the development of the Group's core business. After this transaction, H World Group no longer owns any stake in Accor, but both sides will continue to develop their successful partnership.

As world-renowned hotel groups, H World Group and Accor established strategic partnership with cross shareholding in 2016. Under the agreement, H World Group has the master franchisee rights for Mercure, Ibis and Ibis Styles, as well as co-development rights for Grand Mercure and Novotel in the Greater China Region. By the end of 2022, H World Group operates 468 hotels in China under this agreement, with 143 properties in the pipeline scheduled to open over the next few years. Accor remains a key partner of H World Group in China as both sides push forth their efforts to expand and innovate in the hospitality industry.

H World Group is a key player in the global hotel industry, operating multiple hotel and apartment brands with coverage from luxury to economy markets. H World's brands include Hi Inn, HanTing Hotel, JI Hotel, Starway Hotel, Orange Hotel, Crystal Orange Hotel, Manxin Hotel, Madison Hotel, Joya Hotel, Blossom House, Ni Hao Hotel, CitiGO Hotel, Steigenberger Hotels & Resorts, MAXX, Jaz in the City, IntercityHotel, Zleep Hotels, Steigenberger Icon and Song Hotels.



Topic: Press release summary Sectors: Hospitality
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Latest Press Releases
Hitachi Launches Expanded HMAX Solutions Accelerating Social Innovation Globally Across Industries  
Wednesday, January 7, 2026 11:27:00 AM
Fullerton Health Deepens Specialty Care Capabilities Through Acquisition of Singapore-Based Otolaryngology Practice, The ENT Clinic  
Jan 7, 2026 10:30 HKT/SGT
Radisson Announces Additional High-Grade Drill Results and Further Extends New Mineralization Beneath the Historic O'Brien Gold Mine  
Jan 6, 2026 20:00 HKT/SGT
Hong Kong Toys & Games Fair leads market innovation, debut 'Pop & Play' pavilion opens to industry and public  
Jan 6, 2026 18:50 HKT/SGT
CTF Life Amplifies Ecosystem Synergy  
Jan 6, 2026 15:35 HKT/SGT
Mitsubishi Motors to Celebrate "Delica Festival" with Custom Versions of Delica D:5 and Delica Mini at Tokyo Auto Salon 2026  
Tuesday, January 6, 2026 3:25:00 PM
Mitsubishi Motors Launches the Xforce in Taiwan  
Tuesday, January 6, 2026 1:42:00 PM
"> Biologics License Application for Subcutaneous Formulation of "LEQEMBI(R)" (lecanemab) for the Treatment of Early Alzheimer's Disease Accepted in China
  
Tuesday, January 6, 2026 9:43:00 AM
Asian Financial Forum kicks off 2026 as region's first major event of 2026  
Jan 6, 2026 04:41 HKT/SGT
Notice on the Establishment of a Special Subsidiary  
Jan 5, 2026 21:00 HKT/SGT
More Press release >>
 Events:
More >>
 News Alerts
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: